Decreased TRPV4 activity enhances the uptake of acLDL, but not oxLDL. by Erika J. Gruber (11846156)

Cellular stress decreases TDP-43 levels in patient neurons with the TDP-43 A90V mutation. by Zhijun Zhang (315079)

Subjects:

Inhibition of <i>de novo</i> lipogenesis decreases intracellular HCV RNA. by Sowmya Narayanan (2826308)

Chronic CXCL12 production decreased migrationpotential and increased cell:substrate adhesion. by Ishan Roy (530438)

Inhibition of SKI-1/S1P enzymatic activity using PF-429242 impairs activation of the SREBP pathway and correlates with a dramatic decrease in lipid droplet number and area. by Anastasia Hyrina (3860455)

TBC1D3 selectively decreases IRS-1 Serine phosphorylation. by Marisa J. Wainszelbaum (305403)

EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

“…<p>Immunohistochemical analysis of (A,B) GFAP, (C–F) EphA4 and (G,H) CSPG expression at 2 weeks after spinal cord hemisection and 2 weeks of ephrin-A5-Fc treatment indicated that there was robust GFAP staining in both treated and control mice (A,B). …”

Neutralization potency decreases 6-months post 2^nd vaccine but breadth and potency increase after a 3^rd vaccine dose. by Carl Graham (9415779)

WFS1 deficiency decreases mitochondrial membrane potential and cytosolic ATP level. by Michal Cagalinec (3151077)

“…Values shown are corrected by subtracting the values obtained in the presence of FCCP incubation (5 μM). The red to green fluorescence ratio demonstrated a slight but significant decrease in the <i>Wfs1</i> siRNA group. …”

Effects of 254- and 222-UVC exposure on <i>C</i>. <i>elegans</i> hatching rate. by Kaoru Okamoto Yoshiyama (14526661)

UPLC-DAD profile (270 nm) of phytocannabinoids in the extracts separated in C18 column. by Bruno Musetti (9527085)

CGRP decreases LPS-induced IL-1β mRNA levels. by Aichurek Soultanova (3219459)

miR-181b overexpression decreases cell mitochondrial membrane potential. by Samira Ghorbani (3843895)

WFA induces vimentin degradation and vimentin knockdown decreases cells' sensitivity to WFA. by Guy Lahat (250220)

“…<p><i>A)</i> WFA treatment (5 µM/4 h) results in decreased full-length (FL) vimentin levels and increased expression of vimentin degradation products (VDP) in all STS cells tested. …”

Mutation of stathmin phosphorylation sites decreases sensitivity to bortezomib and influences tubulin polymerization. by Feng Ge (64593)

Decrease of junctional zone area in low protein placentas at E10.5, E17.5 and E18.5. by Paula N. Gonzalez (372538)

The 12 kinds of surfactants selected in the experiment. by Xinhui Luo (11880086)

Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods. by Amrita Banerjee (382658)

Calcineurin acts as a Ca²⁺ sensor for metamodulation of LP I_h in 5nM DA. by Wulf-Dieter C. Krenz (693267)

“…Experiments were performed as described for <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0117965#pone.0117965.g005" target="_blank">Fig. 5</a> using the calcineurin inhibitor, FK506. …”

PD153035 does not decrease mitochondrial Ca²⁺ uptake, nor prevent permeability transition. by Renata A. Cavalheiro (364722)